Cara Mendrick

In Vitro Activities of Posaconazole, Fluconazole, Itraconazole, Voriconazole, and Amphotericin B against a Large Collection of Clinically Important Molds and Yeasts

F. Sabatelli, Rutul Patel, Paul A. Mann et al. · Antimicrobial Agents and Chemotherapy · 2006 · 485 citations · Full text

Application of Real-Time Quantitative PCR to Molecular Analysis of <i>Candida albicans</i> Strains Exhibiting Reduced Susceptibility to Azoles

Andrew S. Chau, Cara Mendrick, F. Sabatelli et al. · Antimicrobial Agents and Chemotherapy · 2004 · 187 citations · Full text

Mutations in <i>Aspergillus fumigatus</i> Resulting in Reduced Susceptibility to Posaconazole Appear To Be Restricted to a Single Amino Acid in the Cytochrome P450 14α-Demethylase

Paul A. Mann, Raulo Parmegiani, Shui-Qing Wei et al. · Antimicrobial Agents and Chemotherapy · 2003 · 185 citations · Full text

In Vitro and In Vivo Activities of SCH 56592 (Posaconazole), a New Triazole Antifungal Agent, against <i>Aspergillus</i> and <i>Candida</i>

Anthony Cacciapuoti, David Loebenberg, Erik Corcoran et al. · Antimicrobial Agents and Chemotherapy · 2000 · 99 citations · Full text

Impact of Antifungal Prophylaxis on Colonization and Azole Susceptibility of <i>Candida</i> Species

Paul A. Mann, Paul M. McNicholas, Andrew S. Chau et al. · Antimicrobial Agents and Chemotherapy · 2009 · 79 citations · Full text